Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Frontiers in Bioscience (Landmark Edition)|October 11, 2025
One Size Does Not Fit All: Precision Combinations for FGFR4-driven CancersEmmy D G FleurenBiochimica Et Biophysica Acta. Reviews on Cancer|August 14, 2021
Precision medicine and phosphoproteomics for the identification of novel targeted therapeutic avenues in sarcomasAshleigh M Fordham, Paul G Ekert, Emmy D G FleurenOncogene|May 2, 2023
Biological and clinical implications of FGFR aberrations in paediatric and young adult cancersLauren M Brown, Paul G Ekert, Emmy D G FleurenNature Reviews. Cancer|January 30, 2016
The kinome 'at large' in cancerEmmy D G Fleuren, Luxi Zhang, Jianmin Wu, et al.Frontiers in Oncology|March 30, 2023
Recent advances on anti-angiogenic multi-receptor tyrosine kinase inhibitors in osteosarcoma and Ewing sarcomaEmmy D G Fleuren, Myrella Vlenterie, Winette T A van der GraafExpert Opinion on Investigational Drugs|October 7, 2017
Directing the use of DDR kinase inhibitors in cancer treatmentInger Brandsma, Emmy D G Fleuren, Chris T Williamson, et al.Current Treatment Options in Oncology|March 9, 2018
Systemic Treatment for Adults with Synovial SarcomaIngrid M E Desar, Emmy D G Fleuren, Winette T A van der GraafBiochimica Et Biophysica Acta|March 4, 2014
Targeting receptor tyrosine kinases in osteosarcoma and Ewing sarcoma: current hurdles and future perspectivesEmmy D G Fleuren, Yvonne M H Versleijen-Jonkers, Otto C Boerman, et al.Molecular Cancer Therapeutics|July 4, 2018
Targeted Therapy-based Combination Treatment in RhabdomyosarcomaAnke E M van Erp, Yvonne M H Versleijen-Jonkers, Winette T A van der Graaf, et al.Biomedicines|December 24, 2021
Enhancing the Potential of Immunotherapy in Paediatric Sarcomas: Breaking the Immunosuppressive Barrier with Receptor Tyrosine Kinase InhibitorsEmmy D G Fleuren, Rachael L Terry, Deborah Meyran, et al.Pageof 4